About this trial
The goal of this observational study is to gather information on background, medical history, symptoms and physical condition, treatment options of people with chronic thromboembolic pulmonary hypertension in real clinical practice in Russia.
The main question it aims to answer is:
Which factors most influence the prognosis of participants?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Presence of a confirmed diagnosis of CTEPH
Disqualifiers
Presence of pulmonary hypertension of a different etiology than CTEPH
Trial population
operable CTEPH, non-operable CTEPH
Trial design
Cohort
Other
Treatments tested in this trial
Pulmonary endarterectomy
Procedure/SurgeryA surgical procedure to remove chronic blood clots from the pulmonary arteries
Balloon pulmonary angioplasty
Procedure/SurgeryA minimally invasive procedure used to treat chronic thromboembolic pulmonary hypertension by dilatating narrowed pulmonary arteries and improving blood flow to the lungs
Pulmonary hypertension-specific therapy
DrugMedical treatment with any PH-specific drugs
Treatment groups
Trial outcomes
Primary outcomes
All-cause mortality
Secondary outcomes
All-cause mortality
Change in distance in 6-minute walk test
Change in mPAP
mPAP assesed during right heart catheterization
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Irina E. Chazova
Lead sponsor
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Sponsor institution